Cargando…

Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers

Gastric cancer (GC) is a leading cause of worldwide cancer-related death. Being a highly heterogeneous disease, the current treatment of GC has been suboptimal due to the lack of subtype-dependent therapies. Peritoneal dissemination (PD) is a common pattern of GC metastasis associated with poor prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanyan, Zhou, Quan, Wang, Haiyong, Zhuo, Wei, Ding, Yongfeng, Lu, Jun, Wu, Guanghao, Xu, Nong, Teng, Lisong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547377/ https://www.ncbi.nlm.nih.gov/pubmed/32785164 http://dx.doi.org/10.3390/cancers12082236

Ejemplares similares

Comprehensive Roles and Future Perspectives of Exosomes in Peritoneal Metastasis of Gastric Cancer
por: Chen, Xiangliu, et al.
Publicado: (2021)

Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome
por: Chen, Yanyan, et al.
Publicado: (2023)

Pan‐cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors
por: Jiang, Junjie, et al.
Publicado: (2021)

Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer
por: Ding, Yongfeng, et al.
Publicado: (2020)

Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer
por: Wu, Mengjie, et al.
Publicado: (2020)

PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study
por: Chen, Yiran, et al.
Publicado: (2022)

Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis
por: Jiang, Junjie, et al.
Publicado: (2020)

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021)

Gastric Cancer in the Era of Precision Medicine
por: Liu, Xi, et al.
Publicado: (2017)

Expression and Prognostic Value of Chromobox Family Proteins in Esophageal Cancer
por: Liu, Jin, et al.
Publicado: (2022)

Combining the Fibrinogen/Albumin Ratio and Systemic Inflammation Response Index Predicts Survival in Resectable Gastric Cancer
por: Zhang, Junbin, et al.
Publicado: (2020)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways
por: Chen, Xiangliu, et al.
Publicado: (2022)

Progress of Gastric Cancer Surgery in the era of Precision Medicine
por: Wang, Yumin, et al.
Publicado: (2021)

Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma
por: Jiang, Junjie, et al.
Publicado: (2020)

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
por: Duan, Jingxian, et al.
Publicado: (2019)

Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer
por: Zhou, Jie, et al.
Publicado: (2019)

Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach
por: Jiang, Junjie, et al.
Publicado: (2022)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

DMET(TM) Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine
por: Agapito, Giuseppe, et al.
Publicado: (2020)

A nomogram to predict prognosis for gastric cancer with peritoneal dissemination
por: Chen, Shi, et al.
Publicado: (2018)

Molecular Characterization of Prostate Cancers in the Precision Medicine Era
por: Giunta, Emilio Francesco, et al.
Publicado: (2021)

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
por: Yu, Xiongfei, et al.
Publicado: (2022)

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
por: Inamdar, Arati A., et al.
Publicado: (2016)

Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine
por: Moore, Donald C., et al.
Publicado: (2023)

A Novel Experimental Mouse Model of Peritoneal Dissemination of Human Gastric Cancer Cells: Different Mechanisms in Peritoneal Dissemination and Hematogenous Metastasis
por: Nishimori, Hidefumi, et al.
Publicado: (2000)

SPHK1‐induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination
por: Yin, Songcheng, et al.
Publicado: (2019)

The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancer
por: Wan, Mingyu, et al.
Publicado: (2023)

INOSA Guidelines in the era of precision medicine
por: Chakraborty, Ranajit
Publicado: (2015)

Cardiovascular Precision Medicine in the Genomics Era
por: Dainis, Alexandra M., et al.
Publicado: (2018)

Cancer Evolution in Precision Medicine Era
por: Karagiannis, Dimitris, et al.
Publicado: (2022)

Antibiotic stewardship in the era of precision medicine
por: Watkins, Richard R
Publicado: (2022)

Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine
por: Choi, Yoon Young, et al.
Publicado: (2015)

A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics
por: Wang, Haiyong, et al.
Publicado: (2021)

Peritoneal Dissemination: A Pending Issue in Gastric Cancer Worth Exploring
por: González-Moreno, Santiago
Publicado: (2009)

Laparoscopic Gastrectomy for Gastric Cancer with Peritoneal Dissemination after Induction Chemotherapy
por: Tsutsumi, Satoshi, et al.
Publicado: (2013)

Integrated fluorescent cytology with nano‐biologics in peritoneally disseminated gastric cancer
por: Watanabe, Megumi, et al.
Publicado: (2018)

Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
por: Sakamoto, Shuichi, et al.
Publicado: (2019)

Disseminated Peritoneal Leiomyomatosis
por: Momtahan, Mozhdeh, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_02r4pf86bt7rem09108gdf4avp